Some pathways (like GDNF) are decreased and some increased (like SPP1, EGF, TFGb, CX3C) in PD compared with control, whereas some pathways (including NRG, PTN, FGF, PSAP) are comparable between control and PD. This evidence concerns the gene EGF and Parkinson disease.